Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 ) Recruitment opened
- Notable: Povetacicept · Primary Membranous Nephropathy (pMN) Primary and study completion pushed from Dec 29, 2028 to Jun 27, 2029
- Notable: Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy and With Tarlatamab, Alone or With Chemotherapy, · Extensive-Stage Small Cell Lung Cancer Primary endpoint(s) modified
- Notable: Silevertinib (BDTX-1535) · Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations Primary completion pushed from Nov 3, 2025 to Mar 2028
- Notable: ICP-B381 · Advanced Solid Tumors Recruitment opened
- Notable: CRMA-1001 · Chronic Hepatitis B Primary and study completion moved earlier from Dec 31, 2032 to Feb 2031
- Notable: VIB305 · Advanced Solid Tumors Primary endpoint(s) modified
- Notable: Automated Versus Manual Oxygen Titration With the EMILY.AI Device · Acute Respiratory Failure Primary endpoint(s) modified
- Notable: Quantitative Refractive Crosslinking in Adults and Presbyopia-Aged Patients in the Philippines Primary completion pushed from Aug 2026 to May 2027
- Notable: Coverage With Evidence Development Study of Percutaneous Image-Guided Lumbar Decompression (PILD) With the Freedom DS Instrument System (FREEDOM-CED) Primary endpoint(s) modified
- Notable: Quantitative Refractive Crosslinking in Adults and Presbyopia-Aged Patients Primary completion pushed from Aug 2026 to May 2027
- Notable: Relationship Between Body Mass Index Percentiles and Radial and Ulnar Artery Diameters in Pediatric Patients Primary endpoint(s) modified
- Notable: Oral Iron · Chronic Kidney Disease Results posted: Nov 18, 2026
- Notable: Esketamine Versus Sufentanil for Sedation in Patients Undergoing ERCP Phase changed: Not applicable → Phase 4
- Notable: Spinal Mobilization Added to Exercise Therapy for Chronic Non-Specific Low Back Pain Enrollment increased: 30 → 60 participants
- Notable: Outcomes of Continuous Positive Airway Pressure Treatment · Obstructive Sleep Apnea and Chronic Pain Primary completion pushed from Dec 2025 to Apr 2027
- Notable: Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device Primary endpoint(s) modified
- Notable: SCLC Blood Collection Study Enrollment increased: 25 → 100 participants
- Notable: Pasteurized Akkermansia Massiliensis LWHK0003 Supplementation · MASLD Primary endpoint(s) modified
- Notable: Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance Primary endpoint(s) modified
- Notable: Hypothermic Temperatures During Hemiarch Surgery Primary endpoint(s) modified
- Notable: Accelerated Optimization of Foundational Medical Therapy in Acute Decompensation of Heart Failure by Telemonitoring: A Pragmatic Multi-center Randomized and Cost-Effectiveness Study Enrollment increased: 80 → 126 participants
- Notable: Application of Mini-Programs in Long-Term Management of Epilepsy in Rural Areas Primary and study completion pushed from Nov 30, 2027 to Nov 30, 2028
- Notable: Phenotypes, Natural History, and Long-Term Outcomes of Arrhythmogenic Cardiomyopathy: The STARTER Registry Primary and study completion dates pushed to Dec 31, 2050
- Notable: Enhanced WELLFOCUS Positive Psychotherapy (EWPPT) and Narrative Enhancement and Cognitive Therapy (NECT) · Schizophrenia Primary endpoint(s) modified
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates